Institutional investors purchased a net $27.8 million shares of KERX during the quarter ended March 2016, and now own 95.91% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE BAUPOST GROUP LLC Bought 33.4 Million shares of Keryx Biopharmaceuticals ...